Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Say it isn't so, Over 10 million hits on that site!! MYDX dream team to look into this also.
No buyers today, no sellers today, no 10q today, OH MY. MYDX dream team on top of this.
Powered by MYDX, Ganga Gold video now 293 views, from 3 views about a week ago. Someones watching. DO WE HIT 300 VIEWS TODAY..
Thanks for posting more pictures of the ECO SMART PEN, just proves it really exists. Waldo will be very, very happy now.
WHAT PEN, I thought the MYDX ECO SMART PEN did not exist. Let me research that with Waldo to see if the pen actually exists. MYDX Dream team is on top of that. MYDX Eco Smart Pen app picture: https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG
WALDO just notified me that 10Q is 'COMING SOON'. He has the MYDX DREAM TEAM WORKING ON IT.
I was informed we would be in the trips by now also, I guess that was just a mydx scammer's guess. DREAM TEAM ON THE JOB, that's a direct quote by the way.
No worries at all here, MYDX DREAM TEAM IS ON THE JOB.
WOW, JUST WOW, What a GREAT find on the website.
LATEST NEWS - Direct quote: “Dream Team” at MYDX to produce the 10-Q.
Here's the link to WALDO'S 10q for MYDX. 'www.MYDX.LONGS.DONT.CARE.com' - I hope it works still, if not try 'www.its.all.part.of.the.mydx.plan.com', that may work.
WALDO HAS THE MYDX 10Q, JUST LOOKED. MYDX longs DON'T care.. It's ALL part of the PLAN.
MYDX #3 on the Most Posted Cannabis Stocks Board, soon to hit number 1.
MYDX RECRUITS MR. CANNABIS GROUP TO OPERATE COMPANY,
https://www.globenewswire.com/news-release/2018/11/13/1650316/0/en/MYDX-RECRUITS-MR-CANNABIS-GROUP-TO-OPERATE-COMPANY.html
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 143 views so far.
SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.
“With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.”
We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study.
This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine.
Marijuana and Potential Long-term Effects Study Goals
The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation.
The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years.
During a visit, participants will be asked to:
Give a small blood sample
Give a small urine sample
Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood
Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad
The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects).
The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders.
The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit.
Given that certain classes of gAPI’s such hemp derived CBD and terpenes might offer “relief” without the “high” THC provides, MyDx intends to partner with leaders in the industry to offer branded products without THC, akin to a “virgin” cocktail, if it finds that these formulations offer the benefits desired and the legal framework to sell them is viable
MYDX interview where Daniel says MYDX has a smart pen and mydx created a smart pen for Mr.Cannibas.
CFN Media Interviews MyDx Inc. (MYDX) at NCIA 2018 https://www.cannabisfn.com/cfnvideo/?id=lXSj78HA
MYDX: Involvement in Legal Proceedings
To the Company’s knowledge, none of our officers or our directors has, during the last ten years:
?
been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
?
had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;
?
been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;
?
been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
?
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;
In January of 2018, MyDx’s Biopharmaceutical division commenced clinical trials on its unique MyDx360 Pain Management Formula, appointed Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran to its Executive Advisory Board on April 24, 2018, secured city and state legal cannabis manufacturing and distribution for its MyDx360 customers in May 2018, and featured the Eco Smart Pen working Prototype on CFN Media in August 2018. The MyDx Analyzer was selected to be used in a large HIV Study by the University of Florida in September 2018. MyDx recruited Mr. Cannabis Group to operate the Company in November 2018, onboarding a new experienced CFO/CEO (Mr. Matthew Bucciero), a leading Harvard neuroscientist (Just Vincent) to its scientific advisory board, and Mr. Erai Beckmann, a seasoned cannabis industry professional, as a member of the Board.
PORTABLE DEVICE AND METHOD FOR VAPORIZING MATERIALS
Publication number: 20190014824
Abstract: A portable device, and more particularly a portable device for vaporizing materials such as oils for inhalation. Also, methods for vaporizing materials and methods of operating portable vaporizing devices. In addition, networks for providing operational features and/or instructions for operation of vaporizing devices and for monitoring and collecting operational data. In preferred embodiments, a vaporizing device and/or methods for operating a vaporizing device wherein the vaporizing device includes one or more of the following features: security features to regulate operation of the device; automatic detection of vaporizing material identity; user experience monitoring and data collection; and/or temperature adjustment of vaporizing material based on detected material for vaporization.
Type: Application
Filed: November 21, 2017
Publication date: January 17, 2019
Inventors: Daniel Yazbeck, Joshua Londano, James Panther, Jason Panther
https://patents.justia.com/inventor/daniel-yazbeck?fbclid=IwAR3UrUz5kPH_YRaYvRl7rF_rrk79Xuj1viP3-YG0c8h60_GAtkKg_KnEII4
IT'S COMING: MYDX Eco Smart Pen app picture: https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG
MYDX at MEDMEN Headquarters. Quote 'MYDX it’s gonna be a great year'
https://www.instagram.com/p/BtMvBI8AbuB/
MYDX Eco Smart Pen and app picture: I guess this picture doesn't exist either. LMAO.
https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG
How's this picture http://sharc-research.org/2018/10/16/sharc-student-andrew-fiore-to-use-portable-marijuana-analyzer-in-pilot-study/ showing a STUDENT AT UNIVERSITY OF FLORIDA holding a CannaDx tester with the quote of
'We are excited to share that student Andrew Fiore will be pursuing the use of the CannaDx sensor in a limited pilot study to evaluate the interest of marijuana analyzers in research participants!
This project highlights SHARC’s leading research that works to answer pressing questions about marijuana use. We are excited to see to follow Andrew’s progress.
The use of this device should not be viewed as an endorsement or validation of the CannaDx sensor by SHARC or the University of Florida'
But I guess non believers could say thats not a real person or not a real CannaDx tester in his hand. Alleged Very FUNNY....
SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.
“With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.”
We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study.
This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine.
Marijuana and Potential Long-term Effects Study Goals
The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation.
The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years.
During a visit, participants will be asked to:
Give a small blood sample
Give a small urine sample
Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood
Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad
The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects).
The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders.
The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit.
MYDX VIDEO, 8,751 views, 3 negative comments out of EIGHT THOUSAND SEVEN HUNDRED FIFTY ONE VIEWS. WOW, Just more proof that MYDX is COMING! https://mclip.tv/video/gTLqyHPtirU/mydx-review-by-slink-johnson-at-high-times-cannabis-cup
MYDX VIDEO: 34,495 views, but no body is watching, lol. https://mclip.tv/video/g6yj281aNig/mydx-portable-cannabis-tester
WALDO HAS THE MYDX QUARTERLY REPORT!!
I agree a move up is imminent, I also do not see pps going to .001. There was a reason buyers were there to scoop up 240 million shares between .0014 and .0022, a couple weeks ago. I believe mydx is wanting to be as sure as they can that the sellers are gone for good. I'm in no rush, got all the time in the world.
I'm STILL waiting for the TRIPS that I was informed was coming for MYDX. LMAO, Haven't seen it, but I keep being told it was going to happen. I'm ready to buy more..
From last shareholder update: In order to increase our ability to gather and track data, we intend on maximizing our production efficiency of the CannaDx product and working towards lowering the overall price point per unit, and we hope as a result we will increase the overall total sales volume of devices sold in Q3 & Q4 of 2019.
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 140 views so far.
MYDX VIDEO: almost 34,495 views, but no body is watching, lol. https://mclip.tv/video/g6yj281aNig/mydx-portable-cannabis-tester
MYDX VIDEO, 8,751 views, 3 negative comments out of EIGHT THOUSAND SEVEN HUNDRED FIFTY ONE VIEWS. WOW, Just more proof that MYDX is COMING! https://mclip.tv/video/gTLqyHPtirU/mydx-review-by-slink-johnson-at-high-times-cannabis-cup
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 132 views so far.
MYDX interview where Daniel says MYDX has a smart pen and mydx created a smart pen for Mr.Cannibas.
CFN Media Interviews MyDx Inc. (MYDX) at NCIA 2018 https://www.cannabisfn.com/cfnvideo/?id=lXSj78HA
MYDX:Involvement in Legal Proceedings
To the Company’s knowledge, none of our officers or our directors has, during the last ten years:
?
been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
?
had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;
?
been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;
?
been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
?
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;
Given that certain classes of gAPI’s such hemp derived CBD and terpenes might offer “relief” without the “high” THC provides, MyDx intends to partner with leaders in the industry to offer branded products without THC, akin to a “virgin” cocktail, if it finds that these formulations offer the benefits desired and the legal framework to sell them is viable
In January of 2018, MyDx’s Biopharmaceutical division commenced clinical trials on its unique MyDx360 Pain Management Formula, appointed Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran to its Executive Advisory Board on April 24, 2018, secured city and state legal cannabis manufacturing and distribution for its MyDx360 customers in May 2018, and featured the Eco Smart Pen working Prototype on CFN Media in August 2018. The MyDx Analyzer was selected to be used in a large HIV Study by the University of Florida in September 2018. MyDx recruited Mr. Cannabis Group to operate the Company in November 2018, onboarding a new experienced CFO/CEO (Mr. Matthew Bucciero), a leading Harvard neuroscientist (Just Vincent) to its scientific advisory board, and Mr. Erai Beckmann, a seasoned cannabis industry professional, as a member of the Board.
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has "not yet" been dismissed.